» Articles » PMID: 12716907

PIASx is a Transcriptional Co-repressor of Signal Transducer and Activator of Transcription 4

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 2003 Apr 30
PMID 12716907
Citations 40
Authors
Affiliations
Soon will be listed here.
Abstract

In response to interleukin 12 (IL-12) stimulation, a latent cytoplasmic transcription factor, Stat4 (signal transducer and activator of transcription 4), becomes tyrosine-phosphorylated and translocates into the nucleus where it binds to DNA to activate transcription. Cofactors that can directly bind and regulate Stat4 activity have not been described. We report here that PIASx, a member of the protein inhibitor of activated STAT (PIAS) family, is a negative regulator of Stat4. PIASx becomes associated with Stat4 following IL-12 stimulation in vivo. PIASx inhibits IL-12-stimulated and Stat4-dependent gene activation in human T cells. PIASx does not inhibit the DNA binding activity of Stat4. Instead PIASx is present in the Stat4-DNA binding complex. Finally the inhibitory activity of PIASx on Stat4-mediated gene activation is abolished by the histone deacetylase inhibitor trichostatin A. Our results suggest that PIASx may function as a co-repressor of Stat4.

Citing Articles

Association of Selected STAT Inhibitors with Prolactin-Induced Protein (PIP) in Breast Cancer.

Jablonska K, Kmiecik A, Nowinska K, Piotrowska A, Suchanski J, Ratajczak-Wielgomas K Int J Mol Sci. 2025; 26(4).

PMID: 40003884 PMC: 11855718. DOI: 10.3390/ijms26041416.


SUMO1 modification of 0N4R-tau is regulated by PIASx, SENP1, SENP2, and TRIM11.

Wada H, Maruyama T, Niikura T Biochem Biophys Rep. 2024; 39:101800.

PMID: 39286522 PMC: 11403297. DOI: 10.1016/j.bbrep.2024.101800.


SUMOylation controls Hu antigen R posttranscriptional activity in liver cancer.

Lachiondo-Ortega S, Rejano-Gordillo C, Simon J, Lopitz-Otsoa F, C Delgado T, Mazan-Mamczarz K Cell Rep. 2024; 43(3):113924.

PMID: 38507413 PMC: 11025316. DOI: 10.1016/j.celrep.2024.113924.


Transient TKI-resistant CD44+pBAD+ blasts undergo intrinsic homeostatic adaptation to promote the survival of acute myeloid leukemia .

Xu Y, Baylink D, Chen C, Tan L, Xiao J, Park B Front Oncol. 2023; 13:1286863.

PMID: 38023123 PMC: 10664142. DOI: 10.3389/fonc.2023.1286863.


The JAK-STAT Signaling Pathway in Epilepsy.

Sun H, Ma D, Cheng Y, Li J, Zhang W, Jiang T Curr Neuropharmacol. 2022; 21(10):2049-2069.

PMID: 36518035 PMC: 10556373. DOI: 10.2174/1570159X21666221214170234.